Clinical Trial: Evaluation of Safety and Tolerability of ATB-320 in Participants With Progressive or Metastatic Solid Tumors

U.S., April 19 -- ClinicalTrials.gov registry received information related to the study (NCT06933524) titled 'Evaluation of Safety and Tolerability of ATB-320 in Participants With Progressive or Metastatic Solid Tumors' on April 04.

Brief Summary: The purpose of this study is to evaluate the safety and tolerability of ATB-320 in patients with progressive or metastatic solid tumors

Study Start Date: June 01

Study Type: INTERVENTIONAL

Condition: Solid Tumors

Intervention: DRUG: ATB-320

IV infusion

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Autotelicbio

Published by HT Digital Content Services with permission from Health Daily Digest....